Christopher Vela, PAC

NPI: 1366728909
Total Payments
$7,196
2024 Payments
$1,472
Companies
35
Transactions
377
Medicare Patients
1,459
Medicare Billing
$72,607

Payment Breakdown by Category

Food & Beverage$7,196 (100.0%)

Payments by Nature

Nature of Payment Amount Transactions Share
Food and Beverage $7,196 377 100.0%

Top Paying Companies

Company Total Records Latest Year
AstraZeneca Pharmaceuticals LP $1,349 58 $0 (2024)
Amgen Inc. $938.01 49 $0 (2024)
PFIZER INC. $522.38 38 $0 (2024)
Takeda Pharmaceuticals U.S.A., Inc. $504.61 19 $0 (2023)
GlaxoSmithKline, LLC. $500.27 24 $0 (2023)
Amarin Pharma Inc. $401.60 21 $0 (2021)
Boehringer Ingelheim Pharmaceuticals, Inc. $309.11 21 $0 (2024)
Merck Sharp & Dohme LLC $274.25 17 $0 (2024)
CSL Behring $271.66 11 $0 (2023)
Regeneron Healthcare Solutions, Inc. $249.98 14 $0 (2023)

Payment History by Year

Year Amount Transactions Top Company
2024 $1,472 88 Amgen Inc. ($358.70)
2023 $1,848 89 AstraZeneca Pharmaceuticals LP ($428.79)
2022 $1,899 83 AstraZeneca Pharmaceuticals LP ($434.80)
2021 $1,977 117 Amarin Pharma Inc. ($401.60)

All Payment Transactions

377 individual payment records from CMS Open Payments — Page 1 of 16

Date Company Product Nature Form Amount Type
12/11/2024 AstraZeneca Pharmaceuticals LP Food and Beverage In-kind items and services $16.41 General
12/10/2024 PFIZER INC. VYNDAQEL (Drug) Food and Beverage In-kind items and services $19.99 General
Category: CARDIOVASCULAR
12/04/2024 AstraZeneca Pharmaceuticals LP FARXIGA (Drug) Food and Beverage In-kind items and services $15.17 General
Category: Cardiovascular and Metabolism
12/03/2024 Amgen Inc. Repatha (Biological) Food and Beverage In-kind items and services $16.60 General
Category: Cardiology
12/02/2024 Merck Sharp & Dohme LLC VERQUVO (Drug), VERQUVO Food and Beverage In-kind items and services $21.02 General
Category: CARDIOVASCULAR
11/21/2024 Boehringer Ingelheim Pharmaceuticals, Inc. JARDIANCE (Drug) Food and Beverage In-kind items and services $11.52 General
Category: DIABETES
11/13/2024 AstraZeneca Pharmaceuticals LP Food and Beverage In-kind items and services $16.41 General
11/12/2024 Actelion Pharmaceuticals US, Inc. OPSUMIT (Drug) Food and Beverage In-kind items and services $17.06 General
Category: Cardiology
11/07/2024 Novo Nordisk Inc Wegovy (Drug) Food and Beverage In-kind items and services $22.61 General
Category: Obesity
11/05/2024 Amgen Inc. Repatha (Biological) Food and Beverage In-kind items and services $17.42 General
Category: Cardiology
11/05/2024 AstraZeneca Pharmaceuticals LP FARXIGA (Drug) Food and Beverage In-kind items and services $16.00 General
Category: Cardiovascular and Metabolism
11/04/2024 Merck Sharp & Dohme LLC VERQUVO (Drug), VERQUVO Food and Beverage In-kind items and services $16.95 General
Category: CARDIOVASCULAR
10/31/2024 Boehringer Ingelheim Pharmaceuticals, Inc. JARDIANCE (Drug) Food and Beverage In-kind items and services $16.74 General
Category: DIABETES
10/31/2024 Boehringer Ingelheim Pharmaceuticals, Inc. JARDIANCE (Drug), SYNJARDY Food and Beverage In-kind items and services $5.00 General
Category: DIABETES
10/23/2024 Actelion Pharmaceuticals US, Inc. OPSUMIT (Drug) Food and Beverage In-kind items and services $27.48 General
Category: Cardiology
10/21/2024 Novo Nordisk Inc Wegovy (Drug) Food and Beverage In-kind items and services $19.28 General
Category: Obesity
10/15/2024 AstraZeneca Pharmaceuticals LP Food and Beverage In-kind items and services $16.47 General
10/09/2024 AstraZeneca Pharmaceuticals LP FARXIGA (Drug) Food and Beverage In-kind items and services $14.89 General
Category: Cardiovascular and Metabolism
10/08/2024 Amgen Inc. Repatha (Biological) Food and Beverage In-kind items and services $10.74 General
Category: Cardiology
10/07/2024 Merck Sharp & Dohme LLC VERQUVO (Drug), VERQUVO Food and Beverage In-kind items and services $17.85 General
Category: CARDIOVASCULAR
10/01/2024 PFIZER INC. VYNDAQEL (Drug) Food and Beverage In-kind items and services $16.76 General
Category: CARDIOVASCULAR
10/01/2024 Novartis Pharmaceuticals Corporation LEQVIO (Drug) Food and Beverage In-kind items and services $15.03 General
Category: Cardiology/Vascular Diseases
09/26/2024 Boehringer Ingelheim Pharmaceuticals, Inc. JARDIANCE (Drug) Food and Beverage In-kind items and services $12.12 General
Category: DIABETES
09/25/2024 Alnylam Pharmaceuticals Inc. ONPATTRO (Drug) Food and Beverage In-kind items and services $19.17 General
Category: Genetic Disease
09/17/2024 AstraZeneca Pharmaceuticals LP Food and Beverage In-kind items and services $16.47 General

Medicare Billing by Year

Year Procedures Beneficiaries Services Submitted Medicare Paid
2023 3 530 582 $109,884 $31,084
2021 3 303 323 $56,745 $13,323
2020 3 626 719 $133,443 $28,201
Total Patients
1,459
Total Services
1,624
Medicare Billing
$72,607
Procedure Codes
9

All Medicare Procedures & Services

9 procedure records from CMS Medicare Utilization

HCPCS Description Setting Year Patients Services Charges Medicare Paid Ratio
99214 Established patient office or other outpatient visit, 30-39 minutes Office 2023 282 318 $83,634 $26,143 31.3%
99213 Established patient office or other outpatient visit, 20-29 minutes Office 2023 54 54 $9,450 $2,964 31.4%
93000 Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report Office 2023 194 210 $16,800 $1,977 11.8%
99214 Established patient outpatient visit, total time 30-39 minutes Office 2021 139 145 $38,135 $10,241 26.9%
99213 Established patient outpatient visit, total time 20-29 minutes Office 2021 43 46 $8,050 $2,013 25.0%
93000 Routine ekg using at least 12 leads including interpretation and report Office 2021 121 132 $10,560 $1,069 10.1%
99214 Established patient office or other outpatient, visit typically 25 minutes Office 2020 330 391 $102,833 $23,346 22.7%
93000 Routine ekg using at least 12 leads including interpretation and report Office 2020 252 282 $22,560 $2,714 12.0%
99213 Established patient office or other outpatient visit, typically 15 minutes Office 2020 44 46 $8,050 $2,140 26.6%

About Christopher Vela, PAC

Christopher Vela, PAC is a Physician Assistant healthcare provider based in Midland, Texas. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 10/27/2011. The National Provider Identifier (NPI) number assigned to this provider is 1366728909.

According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Christopher Vela, PAC has received a total of $7,196 in payments from pharmaceutical and medical device companies, with $1,472 received in 2024. These payments were reported across 377 transactions from 35 companies. The most common payment nature is "Food and Beverage" ($7,196).

As a Medicare-enrolled provider, Vela has provided services to 1,459 Medicare beneficiaries, totaling 1,624 services with total Medicare billing of $72,607. Data is available for 3 years (2020–2023), covering 9 distinct procedure/service records.

Practice Information

  • Specialty Physician Assistant
  • Other Specialties Physician Assistant
  • Location Midland, TX
  • Active Since 10/27/2011
  • Last Updated 08/11/2021
  • Taxonomy Code 363A00000X
  • Entity Type Individual
  • NPI Number 1366728909

Products in Payments

  • Repatha (Biological) $875.87
  • CUVITRU (Biological) $485.57
  • Vascepa (Drug) $401.60
  • DUPIXENT (Biological) $399.05
  • FARXIGA (Drug) $384.09
  • TEZSPIRE (Biological) $374.83
  • ELIQUIS (Drug) $362.91
  • NUCALA (Biological) $357.57
  • JARDIANCE (Drug) $302.87
  • BREZTRI (Drug) $285.45
  • Hizentra (Biological) $271.66
  • VERQUVO (Drug) $243.53
  • LifeVest (Device) $232.56
  • XARELTO (Drug) $156.82
  • VYNDAQEL (Drug) $154.54
  • Xembify (Biological) $146.60
  • LOKELMA (Drug) $126.97
  • TRELEGY ELLIPTA (Drug) $120.78
  • Yupelri (Drug) $112.57
  • FASENRA (Biological) $111.69

Data Sources

Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.

Physician Assistant Doctors in Midland